Newsroom
Sorted by: Latest
-
Riassunto: INNIO firma un accordo definitivo di acquisizione delle attività di Enerflex APAC, ampliando le capacità dei servizi nella regione Asia-Pacifico
JENBACH, Austria--(BUSINESS WIRE)--INNIO Group, fornitore leader di soluzioni e servizi in ambito energetico, oggi ha annunciato la firma di un accordo definitivo con Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) per acquisire le operazioni aziendali post-vendita in Australia, Thailandia e Indonesia. La transazione promuove la strategia di INNIO di rafforzamento della sua presenza nella regione Asia-Pacifico (APAC) e di miglioramento della prossimità ai clienti. La transazione è subordinata alle consue...
-
The NRP Group Breaks Ground on 353-Unit Upscale Community within Medina Station Master Plan in Mesa, Arizona
PHOENIX--(BUSINESS WIRE)--The NRP Group, a vertically integrated, best-in-class developer, builder and manager of multifamily housing, today announced the financial closing and groundbreaking of an upscale, 353-unit multifamily development within Medina Station, a 60‑acre master planned community in Mesa, Arizona. The four‑story, elevator‑served community will be built on a 10‑acre parcel in the northeast quadrant of the master plan, bringing thoughtfully designed apartment homes to families, w...
-
Law Offices of Frank R. Cruz Encourages Navan, Inc. (NAVN) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Navan, Inc. (NAVN) Shareholders To Inquire About Securities Fraud Class Action...
-
Law Offices of Frank R. Cruz Encourages Lakeland Industries, Inc. (LAKE) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Lakeland Industries, Inc. (LAKE) Shareholders To Inquire About Securities Fraud Class Action...
-
ABIONYX Pharma fait le point sur son activité et sa position de trésorerie du 4ème trimestre 2025
TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société biopharmaceutique de nouvelle génération qui développe des thérapies innovantes dans le sepsis et les soins critiques, fondées sur une plateforme technologique exclusive basée sur l’apoA-I, fait le point aujourd’hui sur son activité et sa position de trésorerie au 31 décembre 2025. L’activité consacrée à la découverte et au développement de thérapies innovant...
-
Skunk Train Expands Offerings in Inland Mendocino County
WILLITS, Calif.--(BUSINESS WIRE)--The Skunk Train is launching a major expansion in Willits, introducing a new premier class service, the debut of Railbikes on the inland corridor, and announcing the first-ever circus experience on the Skunk Train. With most of the railway’s 2026 development focused in Willits, inland Mendocino County is taking center stage for the Skunk Train’s newest and most ambitious experiences. 2026 Willits Launch Lineup: The Railcoaster – launching May 16 The Noyo Presid...
-
Deadline Alert: NuScale Power Corporation (SMR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) common stock between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUSCALE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING...
-
ABIONYX Pharma Provides an Update on Its Business and Cash Position for the 4th Quarter of 2025
TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharma company pioneering a new therapeutic era in sepsis and critical care through its proprietary apoA-I–based technology platform, today provided an update on business and cash flow for the fourth quarter ended December 31, 2025. The business dedicated to the discovery and development of innovative therapies, particularly in sepsis and the rar...
-
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). Corcept investors have until April 21, 2026 to file a lead plaintiff motion. IF YO...
-
Avant Closes $200 Million Personal Loan Securitization, Earns Inaugural AAA Rating from Fitch Ratings and KBRA
CHICAGO--(BUSINESS WIRE)--Avant, a leading financial technology company, today announced the successful close of its latest personal loan securitization, a $200 million transaction that marks its first-ever deal to receive AAA ratings from both Fitch Ratings and Kroll Bond Rating Agency (KBRA). The transaction represents the 23rd personal loan securitization since the company’s founding in 2012 and its seventh revolving transaction, underscoring Avant’s consistent track record coupled with stro...